BRIEF-Akebia Therapeutics Inc Says On Nov 12, Co And Medice Amend License Agreement
Reuters
Nov 17
BRIEF-Akebia Therapeutics Inc Says On Nov 12, Co And Medice Amend License Agreement
Nov 17 (Reuters) - Akebia Therapeutics Inc AKBA.O:
AKEBIA THERAPEUTICS INC - ON NOV 12, CO AND MEDICE AMEND LICENSE AGREEMENT - SEC FILING
AKEBIA THERAPEUTICS INC - CO AGREED TO SUPPLY VADADUSTAT DRUG SUBSTANCE TO MEDICE - SEC FILING
AKEBIA THERAPEUTICS INC - MEDICE GRANTED RIGHT TO MANUFACTURE VAFSEO TABLETS - SEC FILING
Source text: [ID:n0001517022-25-000048]
Further company coverage: AKBA.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.